Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Shares, $0.001 par value
Symbol
GRX on NYSE
Shares outstanding
15,447,782
Price per share
$9.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,647,549
Total reported value
$51,236,923
% of total 13F portfolios
0%
Share change
+218,035
Value change
+$1,958,322
Number of holders
54
Price from insider filings
$9.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 13% +7.9% $18,634,814 +$1,167,200 2,054,555 +6.7% Saba Capital Management, L.P. 16 Oct 2025
SIT INVESTMENT ASSOCIATES INC 5.4% $7,912,344 833,756 Sit Investment Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 54 institutional investors reported holding 5,647,549 shares of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX). This represents 37% of the company’s total 15,447,782 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Saba Capital Management, L.P. 13% 2,051,035 +3.8% 0.61% $18,602,887
SIT INVESTMENT ASSOCIATES INC 5.4% 833,756 +31% 0.15% $7,562,000
WELLS FARGO & COMPANY/MN 2.4% 369,670 -8.4% 0% $3,352,906
GAMCO INVESTORS, INC. ET AL 2% 312,226 -8.8% 0.03% $2,831,888
LPL Financial LLC 1.8% 285,653 +0.58% 0% $2,590,869
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 1.8% 277,858 +15% 0.38% $2,520,172
MORGAN STANLEY 1.3% 193,960 +9.1% 0% $1,759,220
Aviance Capital Partners, LLC 1.1% 163,679 +1.1% 0.18% $1,484,567
STEPHENS INC /AR/ 0.78% 120,989 +10% 0.01% $1,097,370
CAPSTONE INVESTMENT ADVISORS, LLC 0.64% 99,441 0% 0.01% $901,930
AQR Arbitrage LLC 0.57% 87,814 -20% 0.02% $796,473
Traub Capital Management LLC 0.55% 85,585 -29% 0.77% $776,256
ABSOLUTE INVESTMENT ADVISERS, LLC 0.55% 85,122 0% 0.1% $772,057
Beacon Pointe Advisors, LLC 0.47% 72,100 -34% 0.01% $653,947
ROYAL BANK OF CANADA 0.42% 65,451 +1101% 0% $594,000
NewEdge Advisors, LLC 0.42% 64,121 +0.26% 0% $581,581
UBS Group AG 0.37% 56,692 -6% 0% $514,196
CSS LLC/IL 0.34% 52,671 -0.58% 0.03% $477,726
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.29% 44,181 -13% 0% $407,787
UHLMANN PRICE SECURITIES, LLC 0.23% 35,029 +15% 0.19% $317,731
Waverly Advisors, LLC 0.22% 33,465 -3.7% 0% $303,528
Janney Montgomery Scott LLC 0.22% 33,330 +0.13% 0% $302,000
RAYMOND JAMES FINANCIAL INC 0.2% 30,974 +84% 0% $280,935
Quarry LP 0.18% 27,469 0% 0.06% $249,144
Creative Planning 0.17% 26,839 -0.31% 0% $243,429

Institutional Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 109,173 $1,050,453 +$144,842 $9.63 5
2025 Q3 5,647,549 $51,236,923 +$1,958,322 $9.07 54
2025 Q2 5,429,514 $51,318,980 +$1,090,583 $9.45 58
2025 Q1 5,185,556 $52,270,856 +$718,989 $10.08 61
2024 Q4 5,270,301 $50,912,869 +$3,900,325 $9.64 67
2024 Q3 4,857,274 $53,072,330 +$3,192,330 $10.95 66
2024 Q2 4,590,471 $43,930,948 +$790,501 $9.58 67
2024 Q1 4,363,392 $44,668,783 +$1,228,402 $10.24 68
2023 Q4 4,287,218 $39,995,577 +$1,936,192 $9.33 71
2023 Q3 4,092,087 $35,099,311 +$881,876 $8.58 71
2023 Q2 3,989,120 $39,717,899 -$844,353 $9.96 71
2023 Q1 4,070,996 $41,067,738 +$665,564 $10.09 69
2022 Q4 4,166,306 $42,829,596 +$1,398,554 $10.28 67
2022 Q3 3,953,651 $37,573,339 -$1,545,108 $9.50 55
2022 Q2 4,110,603 $44,065,987 +$1,682,020 $10.72 58
2022 Q1 3,952,914 $50,670,179 -$3,968,218 $12.82 53
2021 Q4 4,132,189 $56,069,916 -$5,307,668 $13.57 53
2021 Q3 4,560,120 $60,237,215 -$4,106,549 $13.21 50
2021 Q2 4,917,592 $66,379,242 -$3,990,032 $13.50 57
2021 Q1 5,215,180 $64,977,146 -$866,262 $12.46 59
2020 Q4 5,288,796 $63,192,100 +$852,113 $11.95 58
2020 Q3 5,197,261 $53,601,949 -$1,789,951 $10.32 57
2020 Q2 6,530,982 $65,579,924 -$19,032 $10.04 56
2020 Q1 5,436,364 $47,230,797 +$462,488 $8.66 59
2019 Q4 5,385,612 $62,057,060 +$174,363 $11.52 58
2019 Q3 4,970,839 $51,779,513 -$180,673 $10.42 54
2019 Q2 4,987,488 $52,556,237 -$3,086,162 $10.54 55
2019 Q1 5,717,098 $60,083,888 -$612,453 $10.51 52
2018 Q4 5,845,445 $54,073,628 -$7,140,830 $9.25 51
2018 Q3 6,327,302 $70,345,019 +$414,873 $11.02 60
2018 Q2 6,312,211 $64,304,844 -$2,494,100 $10.02 59
2018 Q1 6,558,344 $62,338,874 +$1,055,443 $9.50 60
2017 Q4 6,445,597 $66,579,950 +$10,899,758 $10.32 55
2017 Q3 5,327,106 $53,790,485 +$4,452,101 $10.11 44
2017 Q2 4,882,878 $52,940,521 +$345,583 $10.85 43
2017 Q1 4,855,749 $48,507,480 +$3,262,776 $9.99 43
2016 Q4 4,590,331 $43,313,174 +$139,730 $9.43 44
2016 Q3 4,612,272 $48,015,002 +$458,480 $10.41 45
2016 Q2 4,568,144 $48,752,948 +$2,277,944 $10.67 40
2016 Q1 4,359,502 $43,024,000 -$1,871,286 $9.87 43
2015 Q4 4,537,949 $46,510,000 +$852,055 $10.25 42
2015 Q3 4,450,417 $43,142,000 -$890,578 $9.69 38
2015 Q2 4,510,606 $50,750,282 -$2,187,336 $11.25 33
2015 Q1 4,702,195 $52,939,284 +$224,416 $11.26 35
2014 Q4 4,658,068 $48,527,188 -$3,469,757 $10.42 36
2014 Q3 5,022,715 $49,802,129 +$16,207,656 $9.91 32
2014 Q2 3,332,446 $34,399,455 +$2,998,378 $10.32 33
2014 Q1 2,974,634 $30,765,179 +$3,366,910 $10.34 31